“Two fifths of men in developing countries still smoke or use tobacco, and women are increasingly starting to smoke at younger ages, according to a large international study which found ‘alarming patterns’ of tobacco use,” Reuters reports (Kelland, 8/17). The study, published Friday in the Lancet, “covered enough representative samples to estimate tobacco use among three billion people” and “‘demonstrates an urgent need for policy change in low- and middle-income countries,’ said lead researcher Gary Giovino,” according to CNN (Levs, 8/17). “‘Although 1.1 billion people have been covered by the adoption of the most effective tobacco control policies since 2008, 83 percent of the world’s population are not covered by two or more of these policies,’ said [Giovino],” Reuters adds (8/17).
In this post in the Results for Development Institute’s “Center for Global Health R&D Policy Assessment” blog, Hassan Masum, a consultant at the institute, interviews Alph Bingham, co-founder of Innocentive, an online platform for crowdsourcing technical solutions, about issues surrounding collaborative research and development (R&D) to advance health technologies. According to the blog, the interview is part of a series examining “how collaborative R&D can advance health technologies, and how its success can be gauged” (8/23).
The number of confirmed or suspected cases of Ebola in Uganda has risen to 36, according to a WHO spokesperson, who added the disease remains confined to the rural Kibaale district, NPR’s health blog “Shots” reports. “A team, led by the CDC, WHO and Uganda’s Ministry of Health, are now on the scene to determine the scope of the outbreak and then control it,” according to the blog (Doucleff, 7/31). CNN’s “The Chart” blog reports that 14 people have died of the disease, which has a 25 to 90 percent fatality rate in African outbreaks, according to a WHO fact sheet (7/31).
Access To Quality Health Care, Political Will Essential For Continued Progress In Reducing Maternal Mortality
In this Daily Beast opinion piece, Sarah Brown, an adjunct professor at the Institute for Global Health Innovations at Imperial College in London and global patron of the White Ribbon Alliance for Safe Motherhood, and Sabaratnam Arulkumaran, head of obstetrics and gynecology and deputy head of clinical sciences at St. George’s University of London, highlight the Global Health Policy Summit scheduled to take place in London on Wednesday. Led by Ara Darzi, former U.K. heath minister and chair of the World Economic Forum’s global health group, “this event is driving a new, dedicated approach to find radical answers and new collaborations,” they write, noting, “Our particular stake in the summit is the maternal health session that is specifically taking on an assessment of lessons learned and the next critical steps to take in order to reduce maternal mortality.”
Inter Press Service reports on the successful efforts of Tanzania’s Kigoma Region “to train assistant medical officers to conduct life-saving c-sections at its rural health centers,” allowing pregnant women with complications to deliver at more local facilities instead of having to travel to regional or district hospitals. Tanzania’s maternal mortality rate is high, at 578 deaths for every 100,000 live births, IPS notes. “[A]t one point the Kigoma Region had the highest rate in the country, at 933 per 100,000 live births in the early 1980s,” but “maternal mortality in this region [now] is considered to be lower than in the rest of the country,” according to the news service.
On the first stop of a 10-day tour of Africa, Secretary of State Hillary Clinton stopped at the Phillipe Maguilen Senghor Health Center in Dakar, Senegal, where Awa Marie Coll-Seck, the country’s minister of health, “explained to Secretary Clinton how these operational centers dramatically improve maternal and child health,” according to a post in USAID’s “IMPACTblog.” Coll-Seck “also noted that USAID-supported distribution of insecticide impregnated mosquito nets across the country had drastically reduced the incidence of malaria,” according to the blog, which adds that Clinton “was pleased to hear that the United States is playing a key role in helping meet one of its biggest challenges: decentralizing services so they are available at the village level throughout the country.” In an address several hours later, “Clinton invoked the Senghor center … saying she was highly impressed by the integrated nature of the facility” and that “[i]t was a successful model she hoped could be duplicated throughout Senegal and the entire West African region” (Taylor, 8/1).
The Financial Times on Wednesday published a special report (.pdf) on global health policy to coincide with the Global Health Policy Summit in London. The special report features 10 articles on a variety of topics, including an article examining the complexities of applying health policies, delivering treatment and measuring program performances on a global level; an article highlighting potential strategies for lowering health care costs globally; and an article discussing the need for innovative approaches to combating infectious diseases (8/1).
The XIX International AIDS Conference (AIDS 2012) that took place last week in Washington, D.C., “ignited momentum to shift from ‘fighting AIDS’ to ‘ending AIDS,'” Mohga Kamal-Yanni, senior health adviser at Oxfam International, and Urvarshi Rajcoomer, policy and advocacy adviser at Oxfam in South Africa, write in a Mail & Guardian opinion piece. “Oxfam believes investing in health systems such as infrastructure and health worker, drug supply chain and health information systems, is a critical prerequisite to ending AIDS,” they write. However, “to make this a reality,” pharmaceutical companies, donor governments, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Bank “must now do their part,” they continue.
“Counterfeit medications are a serious and sometimes deadly problem in developing countries,” but “two teams of U.S.-based scientists have developed quick tests can identify counterfeit drugs before they can cause harm,” VOA News reports. Toni Barstis, a chemist at Saint Mary’s College in Indiana, and a team of researchers “presented the new testing methods this week at the annual meeting of the American Chemical Society in Philadelphia,” the news service writes, noting, “Scientists hope their efforts can help prevent the thousands of deaths caused by fake medicines every year.”
In this post in the Global Health Governance Blog, contributing blogger David Fidler, a professor of law at Indiana University’s Maurer School of Law, examines the potential implications of the Affordable Care Act (ACA) on global health law, writing, “In the midst of this constitutional and political moment, I find myself wondering what this seminal American case means, if anything, beyond the United States in the realm of global health.” He concludes, “The lack of clear and immediate connections between the ACA litigation and global health concerns should not blind us … to deeper, more tectonic implications of the ACA’s fate for global health. As in an increasing number of policy contexts, global health practitioners and advocates have much at stake in the outcome of the ACA controversies but no way to influence what happens” (3/28).